Gerardo Cazzato

No ORCID on file · 12 papers in corpus · active 2021-2025

Study types

  • case-report 2
  • other 1
  • review 1

Condition tags

  • endometriosis 3
  • adenomyosis 1
2025
Scientific reports ·doi:10.1038/s41598-025-00906-6

In Europe, endometrial carcinoma was found to be the fourth most common tumor in the female population in 2022. The depth of myometrial invasion is a well-established and crucial prognostic risk factor in endometrial cancer patients and is …

other 2024
Gynecologic and obstetric investigation ·doi:10.1159/000535012

OBJECTIVES: The objective of this multicenter retrospective study aimed to evaluate the association of clinical variables and the incidence of ovarian cancer in patients with BRCA 1-2 mutation carriers who underwent risk-reducing salpingo-o…

2024
Cureus ·doi:10.7759/cureus.52268

Malacoplakia is an uncommon disease characterized by chronic and granulomatous inflammation, which rarely involves the female genital tract. We describe the ecographic and histological evolution of the first case of a patient developing end…

2023
Journal of personalized medicine ·doi:10.3390/jpm13040584

Combined oral contraceptives (COC), are among the most widely used contraceptive methods in the world today. Despite the different changes in terms of estrogen/progestogen combinations and dosages, the thromboembolic risk for a woman who ta…

2023
Journal of clinical medicine ·doi:10.3390/jcm12165202

Follitropin delta (Δ) is a recombinant human follicle-stimulating hormone (rFSH), like natural human FSH, that can stimulate the development and growth of multiple follicles. Treatment with Follitropin-Δ may cause mild to severe adverse rea…

2023
Life (Basel, Switzerland) ·doi:10.3390/life13061312

Fertility preservation (FP) is becoming a critical issue in transgender men who desire biological offspring in the future. The prevalence of transgender individuals in the United States is increasing, and as a result, the demand for gender-…

2023
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics13030543

Leiomyosarcoma (LMS) is a rare type of mesenchymal tumor. Suspecting LMS before surgery is crucial for proper patient management. Ultrasound is the primary method for assessing myometrial lesions. The overlapping of clinical, laboratory, as…

2023
International journal of molecular sciences ·doi:10.3390/ijms24119780

One emerging problem for onco-gynecologists is the incidence of premenopausal patients under 40 years of age diagnosed with stage I Endometrial Cancer (EC) who want to preserve their fertility. Our review aims to define a primary risk asses…

2022
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12123219

Minimally invasive treatment of uterine fibroids usually requires a power morcellation, which could be associated with several complications. A rare sequela is disseminated peritoneal leiomyomatosis. Indeed, recurrence or metastasis in thes…

case-report 2022
Diagnostics ·doi:10.3390/diagnostics12071574

(1) Background: Uterine rupture during pregnancy is a serious obstetric complication with a high incidence of maternal morbidity and mortality. (2) Methods: The present case is a rare event of a uterine rupture occurring in an unscarred ute…

review 2022
Diagnostics ·doi:10.3390/diagnostics12040820

Sonovaginography is a way of assessing gynaecological diseases that can be described as cheap yet accurate and non-invasive. It consists of distention of the vagina with ultrasound gel or saline solution while performing transvaginal sonogr…

case-report 2021
Diagnostics ·doi:10.3390/diagnostics11050827

Mesonephric adenocarcinomas are rare tumors of the female genital tract, thought to arise from embryonic mesonephric remnants, primarily in the cervix and vagina. Conversely, endometrial and ovarian mesonephric adenocarcinomas may have a di…